View in EDS

Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial.

Saved in:
Bibliographic Details
Title: Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial.
Authors: Agbenyega T; Malaria Research Center, Agogo Presbyterian Hospital/Kwame Nkrumah University of Science and Technology, Agogo, Ghana., Schuind AE; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA. Electronic address: aschuind@path.org., Adjei S; Malaria Research Center, Agogo Presbyterian Hospital/Kwame Nkrumah University of Science and Technology, Agogo, Ghana., Antony K; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Aponte JJ; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Buabeng PBY; Malaria Research Center, Agogo Presbyterian Hospital/Kwame Nkrumah University of Science and Technology, Agogo, Ghana., Clemens JD; International Vaccine Institute, Seoul, South Korea; Center for Vaccine Innovation, Seoul, South Korea; UCLA Fielding School of Public Health, Los Angeles, CA, USA., Hossain L; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Kemp TJ; HPV Serology Laboratory, Vaccine, Immunity, and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Mercer LD; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Pinto LA; HPV Serology Laboratory, Vaccine, Immunity, and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Qadri F; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Sukraw K; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Bhat N; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Zaman K; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2025 Aug; Vol. 25 (8), pp. 861-872. Date of Electronic Publication: 2025 Mar 19.
Publication Type: Clinical Trial, Phase III; Equivalence Trial; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40120597
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Agbenyega+T%22">Agbenyega T</searchLink>; Malaria Research Center, Agogo Presbyterian Hospital/Kwame Nkrumah University of Science and Technology, Agogo, Ghana.<br /><searchLink fieldCode="AU" term="%22Schuind+AE%22">Schuind AE</searchLink>; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA. Electronic address: aschuind@path.org.<br /><searchLink fieldCode="AU" term="%22Adjei+S%22">Adjei S</searchLink>; Malaria Research Center, Agogo Presbyterian Hospital/Kwame Nkrumah University of Science and Technology, Agogo, Ghana.<br /><searchLink fieldCode="AU" term="%22Antony+K%22">Antony K</searchLink>; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Aponte+JJ%22">Aponte JJ</searchLink>; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Buabeng+PBY%22">Buabeng PBY</searchLink>; Malaria Research Center, Agogo Presbyterian Hospital/Kwame Nkrumah University of Science and Technology, Agogo, Ghana.<br /><searchLink fieldCode="AU" term="%22Clemens+JD%22">Clemens JD</searchLink>; International Vaccine Institute, Seoul, South Korea; Center for Vaccine Innovation, Seoul, South Korea; UCLA Fielding School of Public Health, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hossain+L%22">Hossain L</searchLink>; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Kemp+TJ%22">Kemp TJ</searchLink>; HPV Serology Laboratory, Vaccine, Immunity, and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Mercer+LD%22">Mercer LD</searchLink>; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Pinto+LA%22">Pinto LA</searchLink>; HPV Serology Laboratory, Vaccine, Immunity, and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Qadri+F%22">Qadri F</searchLink>; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Sukraw+K%22">Sukraw K</searchLink>; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Bhat+N%22">Bhat N</searchLink>; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Zaman+K%22">Zaman K</searchLink>; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101130150%22">The Lancet. Infectious diseases</searchLink> [Lancet Infect Dis] 2025 Aug; Vol. 25 (8), pp. 861-872. <i>Date of Electronic Publication: </i>2025 Mar 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Equivalence Trial; Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101130150 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-4457 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214733099%22">14733099 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40120597
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1473-3099(25)00031-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 861
    Titles:
      – TitleFull: Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Agbenyega T
      – PersonEntity:
          Name:
            NameFull: Schuind AE
      – PersonEntity:
          Name:
            NameFull: Adjei S
      – PersonEntity:
          Name:
            NameFull: Antony K
      – PersonEntity:
          Name:
            NameFull: Aponte JJ
      – PersonEntity:
          Name:
            NameFull: Buabeng PBY
      – PersonEntity:
          Name:
            NameFull: Clemens JD
      – PersonEntity:
          Name:
            NameFull: Hossain L
      – PersonEntity:
          Name:
            NameFull: Kemp TJ
      – PersonEntity:
          Name:
            NameFull: Mercer LD
      – PersonEntity:
          Name:
            NameFull: Pinto LA
      – PersonEntity:
          Name:
            NameFull: Qadri F
      – PersonEntity:
          Name:
            NameFull: Sukraw K
      – PersonEntity:
          Name:
            NameFull: Bhat N
      – PersonEntity:
          Name:
            NameFull: Zaman K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2025 Aug
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1474-4457
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: The Lancet. Infectious diseases
              Type: main
ResultId 1